Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-01

Clinical Trial Update: Lurasidone Non-Interventional Study in Schizophrenia Patients

View source ↗

Summary

A non-interventional study evaluating lurasidone in schizophrenia has completed

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • lurasidone (lurasidone)

Snippet

Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A | Conditions: Schizophrenia | Status: COMPLETED